Franklin Genomic Advancements Etf Price History

HELX Etf  USD 27.13  0.37  1.35%   
Below is the normalized historical share price chart for Franklin Genomic Advancements extending back to February 27, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Franklin Genomic stands at 27.13, as last reported on the 21st of July, with the highest price reaching 27.42 and the lowest price hitting 27.13 during the day.
3 y Volatility
20.62
200 Day MA
28.8247
1 y Volatility
18.94
50 Day MA
26.982
Inception Date
2020-02-25
 
Covid
If you're considering investing in Franklin Etf, it is important to understand the factors that can impact its price. At this stage we consider Franklin Etf to be very steady. Franklin Genomic Adv secures Sharpe Ratio (or Efficiency) of 0.0522, which denotes the etf had a 0.0522 % return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Franklin Genomic Advancements, which you can use to evaluate the volatility of the entity. Please confirm Franklin Genomic's Semi Deviation of 1.4, mean deviation of 1.02, and Downside Deviation of 1.5 to check if the risk estimate we provide is consistent with the expected return of 0.0685%.
Franklin Etf price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0522

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashHELXAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 1.31
  actual daily
11
89% of assets are more volatile

Expected Return

 0.07
  actual daily
1
99% of assets have higher returns

Risk-Adjusted Return

 0.05
  actual daily
4
96% of assets perform better
Based on monthly moving average Franklin Genomic is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Franklin Genomic by adding it to a well-diversified portfolio.
Average Mkt Cap Mil
17.9 K

Franklin Genomic Etf Price History Chart

There are several ways to analyze Franklin Genomic Advancements Etf price data. The simplest method is using a basic Franklin candlestick price chart, which shows Franklin Genomic price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJuly 10, 202528.5
Lowest PriceMay 14, 202525.63

Franklin Genomic July 21, 2025 Etf Price Synopsis

Various analyses of Franklin Genomic's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Franklin Etf. It can be used to describe the percentage change in the price of Franklin Genomic from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Franklin Etf.
Franklin Genomic Price Daily Balance Of Power(1.28)
Franklin Genomic Price Rate Of Daily Change 0.99 
Franklin Genomic Price Action Indicator(0.33)

Franklin Genomic July 21, 2025 Etf Price Analysis

When benchmark price declines in a down market, there may be an uptick in Franklin Genomic Advancements Etf price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Franklin Genomic intraday prices and daily technical indicators to check the level of noise trading in Franklin Genomic Advancements Etf and then apply it to test your longer-term investment strategies against Franklin.

Franklin Etf Price History Data

The price series of Franklin Genomic for the period between Tue, Apr 22, 2025 and Mon, Jul 21, 2025 has a statistical range of 3.07 with a coefficient of variation of 2.99. Under current investment horizon, the daily prices are spread out with arithmetic mean of 26.88. The median price for the last 90 days is 27.07.
OpenHighLowCloseVolume
07/21/2025
 27.42  27.42  27.13  27.13 
07/18/2025
 27.42  27.42  27.13  27.13  56,000 
07/17/2025
 27.72  27.72  27.44  27.50  6,800 
07/16/2025
 27.49  27.58  27.49  27.58  10,892 
07/15/2025
 27.47  27.56  27.36  27.38  27,595 
07/14/2025
 28.04  28.16  28.02  28.02  18,900 
07/11/2025 28.15  28.32  28.05  28.06  44,200 
07/10/2025
 28.50  28.50  28.50  28.50  122.00 
07/09/2025
 28.33  28.36  28.33  28.36  600.00 
07/08/2025
 27.77  28.02  27.77  27.94  3,962 
07/07/2025
 27.73  27.73  27.62  27.65  894.00 
07/03/2025
 28.12  28.12  28.12  28.12  200.00 
07/02/2025
 27.68  28.05  27.68  28.05  1,695 
07/01/2025
 27.71  27.72  27.65  27.68  25,361 
06/30/2025
 27.71  27.71  27.71  27.71  68.00 
06/27/2025
 27.80  27.80  27.62  27.62  235.00 
06/26/2025
 27.65  27.74  27.65  27.74  170.00 
06/25/2025
 27.49  27.64  27.49  27.60  477.00 
06/24/2025
 27.69  27.69  27.69  27.69  7.00 
06/23/2025
 27.19  27.25  27.19  27.22  358.00 
06/20/2025
 27.11  27.27  27.11  27.27  6,926 
06/18/2025
 26.90  27.22  26.90  27.22  323.00 
06/17/2025
 27.02  27.02  27.02  27.02  105.00 
06/16/2025
 27.39  27.44  27.38  27.44  1,854 
06/13/2025
 27.16  27.61  27.16  27.30  820.00 
06/12/2025
 27.55  27.55  27.55  27.55  24.00 
06/11/2025
 27.73  27.73  27.55  27.55  597.00 
06/10/2025
 27.55  27.55  27.53  27.53  2,058 
06/09/2025
 27.16  27.16  27.16  27.16  65.00 
06/06/2025
 26.91  26.91  26.91  26.91  9.00 
06/05/2025
 26.92  26.92  26.51  26.60  1,600 
06/04/2025
 26.81  26.81  26.81  26.81  220.00 
06/03/2025
 26.54  26.54  26.50  26.51  400.00 
06/02/2025
 26.06  26.21  26.06  26.21  200.00 
05/30/2025
 25.89  25.89  25.89  25.89  10.00 
05/29/2025
 26.02  26.02  26.02  26.02  6.00 
05/28/2025
 25.91  25.91  25.84  25.84  1,033 
05/27/2025
 26.11  26.16  26.11  26.16  100.00 
05/23/2025
 24.94  25.77  24.94  25.77  297.00 
05/22/2025
 25.64  25.85  25.64  25.80  700.00 
05/21/2025
 26.30  26.30  25.90  25.90  37,202 
05/20/2025 26.23  26.49  26.23  26.49  177.00 
05/19/2025
 26.13  26.34  26.09  26.34  3,800 
05/16/2025
 26.00  26.19  26.00  26.19  303.00 
05/15/2025
 25.86  25.86  25.86  25.86  57.00 
05/14/2025
 25.61  25.71  25.61  25.63  300.00 
05/13/2025
 26.46  26.48  26.18  26.22  8,788 
05/12/2025
 26.20  26.51  26.19  26.51  2,700 
05/09/2025
 26.31  26.31  25.66  25.66  400.00 
05/08/2025
 26.27  26.27  26.14  26.14  882.00 
05/07/2025 26.06  26.06  26.04  26.04  169.00 
05/06/2025
 26.62  26.62  25.95  26.01  600.00 
05/05/2025
 27.28  27.28  27.28  27.28  103.00 
05/02/2025
 27.49  27.49  27.49  27.49  13.00 
05/01/2025
 26.91  26.95  26.83  26.88  1,300 
04/30/2025
 27.24  27.24  27.24  27.24  159.00 
04/29/2025
 27.24  27.24  27.24  27.24  112.00 
04/28/2025
 27.07  27.07  27.07  27.07  14.00 
04/25/2025
 26.85  26.99  26.85  26.99  200.00 
04/24/2025
 26.74  27.13  26.74  27.13  400.00 
04/23/2025
 26.80  27.01  26.60  26.60  535.00 

About Franklin Genomic Etf history

Franklin Genomic investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Franklin is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Franklin Genomic Adv will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Franklin Genomic stock prices may prove useful in developing a viable investing in Franklin Genomic
Under normal market conditions, the fund invests at least 80 percent of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. Franklin Genomic is traded on BATS Exchange in the United States.

Franklin Genomic Etf Technical Analysis

Franklin Genomic technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
A focus of Franklin Genomic technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Franklin Genomic trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Latest Portfolios Now

   

Latest Portfolios

Quick portfolio dashboard that showcases your latest portfolios
All  Next Launch Module

Franklin Genomic Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Franklin Genomic's price direction in advance. Along with the technical and fundamental analysis of Franklin Etf historical price patterns, it is also worthwhile for investors to track various predictive indicators of Franklin to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Franklin Genomic Adv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Franklin Genomic's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Franklin Genomic Advancements Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Franklin Genomic Advancements Etf:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Franklin Genomic Advancements. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
The market value of Franklin Genomic Adv is measured differently than its book value, which is the value of Franklin that is recorded on the company's balance sheet. Investors also form their own opinion of Franklin Genomic's value that differs from its market value or its book value, called intrinsic value, which is Franklin Genomic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Franklin Genomic's market value can be influenced by many factors that don't directly affect Franklin Genomic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Franklin Genomic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Franklin Genomic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Franklin Genomic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.